1. Introduction {#sec1}
===============

Excessive levels of reactive oxygen species (ROS), such as high concentrations of H~2~O~2~, can attack bases in nucleic acids, amino acid side chains in proteins, and double bonds in unsaturated fatty acids resulting in damage of biomacromolecules \[[@bib1]\]. Depending on H~2~O~2~ concentration and antioxidant capacity of a given cell type, such damage can trigger oxidative stress-response pathways leading to altered gene expression or increased proteolysis \[[@bib2]\], stress-induced premature senescence \[[@bib3],[@bib4]\], or cell death \[[@bib5],[@bib6]\]. Therefore, accurate measurement of protein expression in addition to a determination of cysteine oxidation would provide an important layer of information when investigating not only H~2~O~2~-induced phenotypes but the response to oxidative stress in general.

Given its specificity to sulfhydryl groups, iodoacetyl tandem mass tag (iodoTMT) was efficiently used for quantification of reversibly modified cysteines \[[@bib7],[@bib8]\]. However, the cysteine free thiols are very prone to artificial oxidation during sample preparation, which might diminish an accurate comparison between steady state and perturbed redox homeostasis. In this report, we modified iodoTMT method by combining it with Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) \[[@bib9]\] which enabled us to combine control and treated samples prior to iodoTMT labeling. Using a model of H~2~O~2~-induced oxidative stress we demonstrated that SILAC-iodoTMT labeling represents a powerful technique for simultaneous assessment of redox and proteome changes related to H~2~O~2~-treatment on a global scale. Furthermore, the combination of both SILAC and iodoTMT quantitative data can provide hints for the discrimination of apparent shifts in cysteine redox states caused by changes in peptide/protein abundances.

2. Material and methods {#sec2}
=======================

For a detailed description of all methods see the supplementary document.

2.1. Cell cultivation and treatment {#sec2.1}
-----------------------------------

SILAC labeling of hTERT RPE-1 cells was done by using l-arginine \[^13^C~6~, ^15^N~4~\] and l-lysine \[^13^C~6~\]. Cells were treated with 100 μM H~2~O~2~ and harvested after 5 min, 60 min, and 32 h together with the untreated control. The experiment was done in biological duplicate with swapped SILAC groups.

2.2. Sequential iodoTMT labeling and protein digestion {#sec2.2}
------------------------------------------------------

For each time interval, a control (Ctrl) cell lysate labeled in the light/heavy SILAC channel was mixed with an equal amount of H~2~O~2~-treated lysate of the corresponding heavy/light SILAC channel. Free --SH groups were labeled by the first iodoTMT label (TMT1). Subsequently, proteins were precipitated using cold (−20 °C) acetone. The pellet was re-dissolved in lysis buffer and incubated with Tris(2-carboxyethyl)phosphine hydrochloride (TCEP) to reduce the reversibly oxidized cysteines \[[@bib10]\]. Reduced cysteines were then labeled by second iodoTMT label (TMT2), and the reaction was quenched by 200 mM cysteine. After second acetone precipitation, proteins were digested using rLys-C (Wako) at 37 °C for 3 h followed by sequencing grade trypsin (Promega) digestion at 37 °C overnight at 1 : 50 ratio (enzyme/substrate). Digestion was stopped by the addition of trifluoroacetic acid (TFA), and precipitated SDC was removed by extraction in water-saturated ethyl acetate. Samples were desalted, and liquid chromatography/mass spectrometry (LC-MS) analysis was performed as described in the supplementary document. Survey MS and MS/MS spectra were processed in MaxQuant 1.6.6.1 \[[@bib11]\]. For data evaluation, output files from MaxQuant were processed in Perseus 1.6.2.2 and R 3.1.3. The mass spectrometry proteomics data and MaxQuant output text files have been deposited to the ProteomeXchange Consortium via the PRIDE \[[@bib12]\] partner repository with the dataset identifier PXD012504.

3. Results and discussion {#sec3}
=========================

3.1. Development of SILAC-iodoTMT method {#sec3.1}
----------------------------------------

In this work, we introduced SILAC-iodoTMT labeling method to effectively capture the redox and proteome changes without cysteine enrichment, preserving thus information about the whole proteome. The workflow of this approach is depicted in [Fig. 1](#fig1){ref-type="fig"}A. The principal advantage of the described approach combining SILAC and iodoTMT labeling is that it enables to simultaneously quantify treatment-induced alterations in protein abundance and cysteine-containing peptide oxidation/reduction. While peptide SILAC precursor ratios correlate with changes in protein expression/degradation, MS/MS fragmentation spectra of cysteine-containing peptides include also signals of iodoTMT reporter ions proportional to the fraction of reduced/oxidized --SH groups. MS parameters fundamental for efficient LC-MS analysis (isolation window and normalized collision energy) were found to be a good compromise in terms of a sufficient abundance of iodoTMT reporters in MS/MS spectra of cysteine-containing peptides and high MS/MS identification rate ([Supplementary Fig. S1](#appsec1){ref-type="sec"}). An important methodological requirement is that for the comparison of redox state between two experimental groups, both complete SILAC pairs (both light and heavy) of cysteine-containing peptides need to be fragmented and identified ([Fig. 1](#fig1){ref-type="fig"}A). Hence, about half of all identified cysteine-containing peptides should belong to heavy SILAC channel. Test LC-MS analysis of hTERT RPE-1 cells showed that heavy SILAC forms made up approximately 45% of the total identification count of cysteine-containing peptides ([Fig. 1](#fig1){ref-type="fig"}B). However, both SILAC variants were identified by MS/MS for the majority of iodoTMT-labeled peptides ([Fig. 1](#fig1){ref-type="fig"}C). Importantly, iodoTMT ratios obtained from the corresponding light and heavy SILAC peptides correlated well with Spearman correlation coefficient of 0.85 ([Fig. 1](#fig1){ref-type="fig"}D), as expected from the unperturbed sample. These results encouraged the application of SILAC-iodoTMT labeling for the monitoring of proteome redox state in hTERT RPE-1 cells under the conditions of oxidative stress.Fig. 1Sequential SILAC-iodoTMT labeling. (A) Scheme of labeling workflow. (B) Proportion of light and heavy SILAC-labeled cysteine-containing peptides identified by MS/MS with ^13^C~6~^15^N~4~-Arg and ^13^C~6~-Lys as variable modifications. Data from two technical replicates were combined. (C) Venn diagram showing the proportion of cysteine-containing peptides with light and heavy SILAC counterpart fragmented. Data from two technical replicates were combined. (D) Correlation of iodoTMT log-ratios of the respective light and heavy SILAC cysteine-containing peptides. Data were averaged from two technical replicates.Fig. 1

3.2. Quantification of late global protein and redox changes post H~2~O~2~-treatment {#sec3.2}
------------------------------------------------------------------------------------

To evaluate the applicability of SILAC-iodoTMT approach for simultaneous redox and proteome measurement, we selected a sublethal H~2~O~2~ dose (100 μM) and harvested the treated hTERT RPE-1 cells (Supporting Results and Discussion) in the following time-interval after H~2~O~2~ exposure; 5 min, 60 min, and 32 h. We found no changes in protein levels related to H~2~O~2~-treatment at early time points (5 and 60 min; [Supplementary Fig. S3A](#appsec1){ref-type="sec"}). However, the significant protein expression changes and increase of intracellular ROS were detected 32 h *post* treatment ([Fig. 2](#fig2){ref-type="fig"}A, [Supplementary Fig. S2A](#appsec1){ref-type="sec"}). The most upregulated proteins included a pro-inflammatory cytokine interleukin-1β (IL1B, [Fig. 2](#fig2){ref-type="fig"}B), p53-dependent proteins such as ferredoxin reductase (FDXR), TP53-induced glycolysis and apoptosis regulator (TIGAR), and p53-independent apoptosis inductor Fas. On the contrary, members of the DNA replication licensing MCM complex involved in cell cycle progression were the most downregulated ([Fig. 2](#fig2){ref-type="fig"}C) \[[@bib13], [@bib14], [@bib15], [@bib16], [@bib17]\]. Enrichment analysis revealed consistently up- or down-regulated GOBP classes including DNA damage response, DNA replication, or regulation of apoptosis ([Supplementary Figs. S3B and C](#appsec1){ref-type="sec"}). Altogether, the described protein expression changes in 32-h-sample correlated well with the observed H~2~O~2~-induced phenotype ([Supplementary Fig. S2B](#appsec1){ref-type="sec"}) and confirmed biological relevance of our data on proteome level.Fig. 2Hydrogen peroxide-induced changes in protein expression and cysteine thiol oxidation/reduction in 32 h after H~2~O~2~-treatment. (A) Correlation of protein expression between two biological replicates in 32 h time-interval is shown. The most significant protein expression changes (one-sample *t*-test, Benjamini-Hochberg FDR \< 0.05, \|log2FC\| \> 2SD) were marked with blue (downregulated) or red (upregulated) dots. Confirmation of expression changes of IL-1β (B) and MCM3 (C) using immunoblotting. Mean and standard deviation from three independent biological replicates are shown. Protein expression was normalized on corresponding loading control (GAPDH). Statistical significance was calculated by two-sided unpaired *t*-test, \*\* p-value \< 0.01, \* p-value \< 0.05. (D) Global increase of cysteine oxidation was detected 32 h after H~2~O~2~-treatment. Correlation between two biological replicates in 32-h time-interval is shown. Hydrogen peroxide-sensitive cysteine peptides significantly upregulated in both biological replicates (two-sample *t*-test, permutation-based FDR \< 0.05) were marked with red dots. (E) The most significant examples of hydrogen peroxide-sensitive proteins are shown (paired *t*-test p-value \< 0.02, mean difference \> 0.05). (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 2

Several studies analyzing sensitivity of cellular thiols to hydrogen peroxide in the early post-recovery phase have been already published \[[@bib18], [@bib19], [@bib20]\]. However, these studies focused on the very early time points such as 5, 10, or 15 min. Due to SILAC-iodoTMT method, we could investigate redox and protein expression imbalances that might potentially develop as a secondary or late/delayed response to oxidative damage in a much longer time frame. As shown in [Fig. 2](#fig2){ref-type="fig"}D, a global redox change was detected after 32 h *post* treatment as demonstrated by a significant shift of median relative oxidation levels in Ctrl and H~2~O~2~-treated sample ([Supplementary Fig. S3D](#appsec1){ref-type="sec"}). The list of the most significant redox-sensitive proteins included e.g. ribosomal proteins, translation elongation factors, glycolytic enzymes, and chaperones ([Fig. 2](#fig2){ref-type="fig"}E). Importantly, most of these H~2~O~2~-sensitive proteins have been already listed in the redox database RedoxDB \[[@bib21]\] and in the previously reported redoxomes \[[@bib18],[@bib22]\], providing an important confirmation of biological relevance of our data.

3.3. Selective reduction of resolving peroxiredoxin cysteine residues early (5 and 60 min) post H~2~O~2~-treatment {#sec3.3}
------------------------------------------------------------------------------------------------------------------

Peroxiredoxins (Prx) are primarily employed as fast H~2~O~2~ scavengers \[[@bib23]\]. In our results, peroxiredoxins were the only proteins of which resolving (C~R~) and peroxidatic (C~P~) cysteine residues were significantly changed in redox state in 5 and 60 min after H~2~O~2~-treatment ([Table 1](#tbl1){ref-type="table"}, see Supplementary document). Surprisingly, we found these peroxiredoxin cysteine residues apparently shifted to the 'reduced' form ([Supplementary Fig. S3E](#appsec1){ref-type="sec"}). To explain somewhat contradictory findings that these cysteines are reduced by H~2~O~2~-treatment, we correlated cysteine redox states with changes in abundance of the respective peptides. Despite unchanged protein expression, SILAC H~2~O~2~/Ctrl log-ratios of Prx peptides carrying reduced C~R~ (C173, C173/245, C211) and Cys 91 (C91) were higher than zero ([Fig. 3](#fig3){ref-type="fig"}A). It indicated that these peptides were upregulated as soon as 5 min after H~2~O~2~-treatment in contrast to other non-cysteinyl peptides from Prx proteins ([Fig. 3](#fig3){ref-type="fig"}B) or other proteins (see Supplementary document, [Supplementary Fig. S4](#appsec1){ref-type="sec"}). We hypothesize that it might point to the 'mobilization' of C~R~ cysteines in a fraction of Prx proteins due to stressful condition ([Fig. 4](#fig4){ref-type="fig"}A). In absence of H~2~O~2~, this 'shielded' portion of Prx C~R~ *in vivo* would not be amenable to TCEP reduction after lysis (e.g. concealed by modification) and therefore inapproachable for iodoTMT labels. In this assumption, H~2~O~2~-treatment may stimulate cells to mobilize these C~R~ by transforming them into active reduced forms. Thus, increasing MS signal in H~2~O~2~ SILAC channel and boosting the abundance of the reporter ion correspond with the reduced form of these Prx peptides.Table 1Peroxiredoxin cysteine-containing peptides significantly reduced after 5 and/or 60 min of H~2~O~2~-treatment (+) in both biological replicates. Each peptide is designated by Uniprot identifiers (protein and gene name) and sequence. Position and type of cysteines (C~P~/C~R~) are introduced.Table 1Protein NameGene NameSequenceCys positionActivity5 min60 minQ06830PRDX1HGEVCPAGWKPGSDTIKPDVQK173C~R~+--Q06830; Q13162PRDX1; PRDX4HGEVCPAGWK173, 245C~R~++P30048-2PRDX3AFQYVETHGEVCPANWTPDSPTIK211C~R~++P30041PRDX6DINAYNCEEPTEK91--++P30041PRDX6DFTPVCTTELGR47C~P~++Fig. 3Cysteine reduction in peroxiredoxin peptides was related to higher intensity of H~2~O~2~-treated sample in SILAC channel. (A) Scatter plot of SILAC (y-axis) and ox/red (x-axis) ratio of successfully quantified cysteine-containing peptides in 5 and 60 min after H~2~O~2~-exposure. Significantly reduced peroxiredoxin cysteine-containing peptides were marked in red. Data were combined from two biological replicates. (B) H~2~O~2~/Ctrl SILAC ratio of peroxiredoxin peptides with the cysteine residue (Prx-Cys) and with the absence of cysteine (Prx) 5 and 60 min *post* H~2~O~2~-treatment. Intensity of cysteinyl Prx peptides was different in H~2~O~2~ and Ctrl SILAC channel in contrast to Prx peptides without cysteine, whose SILAC ratio is unchanged in both 5 and 60 min after H~2~O~2~-treatment. The peptide with peroxidatic C47 of Prx 6 had apparent decreased intensity in H~2~O~2~ SILAC channel compared to resolving cysteine residues listed in [Table 1 (C)](#tbl1){ref-type="table"} Scatter plot of SILAC ratio (y-axis) and relative oxidation (x-axis) of successfully quantified cysteine-containing peptides in 32-h sample. Peroxiredoxin cysteine-containing peptides significantly reduced in 5 and 60 min samples are marked in red. Data were combined from two biological replicates. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)Fig. 3Fig. 4SILAC intensity of resolving cysteine-containing peptide "HGEVCPAGWKPGSDTIK-PDVQK" of Prx 1 (A) and peroxidatic cysteine-containing peptide "DFTPVCTTELGR" of Prx 6 (B). An increase of MS1 intensity in H~2~O~2~ channel might be caused by a proportion of Cys 173 moieties, which are inaccessible for TCEP reduction and iodoTMT labeling. On the contrary, we identified peroxidatic Cys 47 residue modified with dioxy (-SO~2~H) and trioxy (-SO~3~H) sites, which probably caused a reduced intensity of cysteines with free thiols and disulfide bond in H~2~O~2~ channel.Fig. 4

We could only speculate, how or if these C~R~ are modified in the absence of a stress-related condition. TCEP is an efficient thiol-free reducing agent strong enough to reduce all reversible cysteine oxidation states \[[@bib10]\]. However in Ctrl samples, the unknown modification probably protected C~R~ against TCEP reduction following by cysteine labeling by TMT2 ([Fig. 1](#fig1){ref-type="fig"}A). Peroxidatic cysteine residues are prone to over-oxidation to C~P~-SO~2~H and C~P~-SO~3~H \[[@bib24]\], while higher oxidation state of C~R~ has been reported only in few studies \[[@bib25],[@bib26]\]. Based on these findings, we performed an independent search to quantify higher oxidation states of thiols. By implementation of the --SO~2~H and --SO~3~H sites as variable modification in MaxQuant search together with iodoTMT label, we identified only peroxidatic Cys 47-peptide modified by iodoTMT label and in diox- and triox-state as illustrated in [Fig. 4](#fig4){ref-type="fig"}B. This peptide was distinctly downregulated up to 32 h *post* treatment based on SILAC H~2~O~2~/Ctrl ratio ([Fig. 3](#fig3){ref-type="fig"}A, B, and C), suggesting that H~2~O~2~ might decrease irreversibly the yield of C~P~ susceptible to iodoTMT labeling. However, we did reveal neither --SO~2~H/-SO~3~H sites, nor other modification except iodoTMT label of C~R~ in Prx. Thus the peroxiredoxin "shield" for resolving cysteines still remains to be identified. Nevertheless, [Fig. 3](#fig3){ref-type="fig"} showed that the presented methodology of SILAC-iodoTMT labeling is able to discriminate functionally different cysteine sites.

4. Conclusions {#sec4}
==============

In this work, we introduced SILAC-iodoTMT workflow as an effective tool for mapping changes of protein level as well as a shift in cysteine oxidation and reduction. Using SILAC-iodoTMT we efficiently quantified global protein and redox changes up to 32 h after H~2~O~2~-treatment. The biological relevance of our data proved the applicability of SILAC-iodoTMT to simultaneously quantify changes in protein and redox imbalance. In addition, we revealed a selective reduction of active cysteine residues of peroxiredoxin 1, 3, 4, and 6 relatively early (5 and 60 min) after exposure to H~2~O~2~. We presume there is a portion of cysteine resolving residues modified under normal condition and selectively reduced upon the stressful condition such as H~2~O~2~ exposure. Altogether, the combination of SILAC and iodoTMT presented in our work enabled us to highlight functional cysteines involved in H~2~O~2~ scavenging and quantify their redox dynamics.
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